Top Trends Transforming the MicroRNA Market Landscape in 2025: Innovative Mirna Probe Customization Services Elevate Research And Clinical Applications

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the MicroRNA Industry Market Size Be by 2025?
In recent years, the microrna market has witnessed notable growth. The market size is projected to expand from $1.33 billion in 2024 to $1.58 billion in 2025, recording a compound annual growth rate (CAGR) of 18.9%. The notable growth during the historical period can be credited to the discovery of microRNAs, advancement in RNA interference (RNAi), genome sequencing projects, the rise of computational biology and bioinformatics, as well as research in extracellular vehicles (EVs).

What's the Long-Term Growth Forecast for the MicroRNA Market Size Through 2029?
The market for microrna is anticipated to experience substantial expansion in the upcoming years, reaching a value of $3.11 billion by 2029 with a compound annual growth rate (CAGR) of 18.5%. The surge in size over this forecasted period can be credited to various factors such as advances in clinical translation, regulatory networks and systems biology, further development of microRNA-centric therapies, discovery of potential therapeutic avenues, and biomarker identification. Key trends projected to influence the market during this period encompass progressive technology, bioinformatics, data evaluation, conservational practices across species, microbiome correlations, and functional mechanisms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

What Are the Key Growth Drivers Fueling the MicroRNA Market Expansion?
The surge in cancer cases is projected to fuel the expansion of the microRNA market. Cancer, a complicated illness marked by unchecked cell growth and propagation, frequently results in malignant tumors that invade nearby tissues and metastasise to far-flung organs, posing substantial health threats. The rise in cancer cases is attributable to a multitude of factors, including an ageing population, lifestyle decisions such as smoking and bad eating habits, environmental contaminants, and more effective diagnostic methods leading to early detection. MicroRNA is merged with traditional cancer treatments to boost drug sensitivity and enhance patient outcomes. Along with acting as treatment aids, miRNAs also work as diagnostic and prognostic biomarkers, assisting in the identification of cancer types, prediction of disease evolution, and monitoring of treatment reactions. For example, the National Cancer Institute, a US government agency, reported around 20 million new cases and 9.7 million cancer-related deaths in 2022, and it is expected that by 2040, the annual figures will land at 15.3 million deaths and 29.9 million new cases. Consequently, the growing incidence of cancer is facilitating the expansion of the microRNA market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

What Are the Key Trends Driving MicroRNA Market Growth?
Key companies in the microRNA market are prioritizing the development of sophisticated solutions like MiRNA probe customization services. These are designed to cater to the specific requirements of researchers and clinicians, improve the precision of miRNA detection, and support numerous applications. The provision of MiRNA probe customization services involves the creation and production of distinct probes specific to individual microRNAs (miRNAs). These are essential for a vast range of research and clinical applications, by biotechnology and molecular biology firms. For example, Abnova Corporation, a biotech enterprise based in Taiwan, introduced improved miRNA probe customization services in September 2023. Additionally, they launched a new selection of cataloged miRNA probes to accommodate the various needs of academic, industrial, and research communities involved in miRNA studies. These probes are pivotal for the detection and accurate positioning of miRNAs, tiny, non-coding RNA molecules that play a significant role in multiple biological processes. Abnova's custom-made services guarantee maximum specificity and little or no cross-reactivity, making them ideal for evaluating samples with limited miRNA content.

How Is the MicroRNA Market Segmented?
The microrna market covered in this report is segmented -

1) By Products: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Subsegments:
1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers
2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Which Companies Are Leading the Charge in MicroRNA Market Innovation?
Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Which Regions Are Leading the Global MicroRNA Market in Revenue?
North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.